These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4467346)

  • 1. [Systematics of the bases of local dermotherapy, with reference to the customary formulae of the PhH, DAB, USP, Pharm. franç. and PM (author's transl)].
    Spirig H; Müller KH
    Ther Umsch; 1974 May; 31(5):343-53. PubMed ID: 4467346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the prescriptions and nomenclature of dermatologic agents and in drug compounding implemented by the German Pharmacopoeia, 7th edition (DAB 7)].
    Bolle I
    Dermatol Monatsschr; 1971 Oct; 157(10):749-57. PubMed ID: 5144815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations].
    Vennat B; Pouget MP; Pourrat A
    Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prescriptions for individually prepared dermatologic agents. I].
    Fekárová A; Gruntová Z; Hornácková M
    Cesk Farm; 1992 Jul; 41(4-5):158-61. PubMed ID: 1451194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermal reaction against hydrocortisone in different ointment bases (author's transl)].
    Wohlrab W; Zaumseil RP
    Dermatol Monatsschr; 1982 Apr; 168(4):236-42. PubMed ID: 7106335
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prescription tips: ready-made dermatologic agents in individual prescriptions].
    Hautarzt; 2008 Apr; 59(4):270-1. PubMed ID: 18389156
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].
    Stassen T; Piette M; Kinget R; Delattre L
    J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prescription reference--drug vehicle system: decisive for effect].
    Wolf G
    Hautarzt; 2007 Dec; 58(12):1008-9. PubMed ID: 18368698
    [No Abstract]   [Full Text] [Related]  

  • 9. [What has become of extemporaneous mixtures?].
    Brasseur D
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S37-9. PubMed ID: 17563713
    [No Abstract]   [Full Text] [Related]  

  • 10. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 11. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of ceratolytics and moisturizers on the bio-availability of triamcinolone acetonide following topical application (author's transl)].
    Gloor M; Lindemann J
    Dermatol Monatsschr; 1980 Feb; 166(2):102-6. PubMed ID: 7398967
    [No Abstract]   [Full Text] [Related]  

  • 13. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
    Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the preparation and testing of aloe extract, with a suggestion for DAB 7].
    Bogs U; Zessin G
    Pharmazie; 1966 Sep; 21(9):547-50. PubMed ID: 6002471
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the preparation and testing of rhei extract, with a suggestion for DAB 7].
    Bogs U; Zessin G
    Pharmazie; 1966 Sep; 21(9):553-5. PubMed ID: 6002472
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the preparation and testing of frangulae extract, with a suggestion for DAB 7].
    Bogs U; Zessin G
    Pharmazie; 1966 Sep; 21(9):550-2. PubMed ID: 4883034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prescription moderated preparation of bacteria non-contaminated eyedrop solutions and eye ointment 1].
    Frauch P
    Pharm Acta Helv; 1970 Jan; 45(1):1-17. PubMed ID: 4908302
    [No Abstract]   [Full Text] [Related]  

  • 19. What pharmacists can expect in the upcoming USP Dispensing Information.
    Eichelberger BM
    Am J Hosp Pharm; 1978 Oct; 35(10):1313-4. PubMed ID: 696735
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of newly revised sterile medication compounding guidelines USP {797} on allergy vial preparation.
    Lin SY; Houser SM; Gross G; Aaronson D
    Otolaryngol Head Neck Surg; 2008 Jul; 139(1):5-6. PubMed ID: 18585553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.